Epiq Scripts IP, LLC – Trademark Portfolio

Entity Type: 16

Epiq Scripts IP, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 7 are pending. The owner is based in Richardson, TX.

465 West President George Bush Highway

Richardson, TX 75080

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Epiq Scripts IP, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (3 filings)

Treatment of materials

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Epiq Scripts IP, LLC have?

Epiq Scripts IP, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 7 pending, 1 abandoned.

What trademark classes does Epiq Scripts IP, LLC file in?

Epiq Scripts IP, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Epiq Scripts IP, LLC's trademark registration success rate?

Epiq Scripts IP, LLC has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 7 applications are pending review.